Latest News about Chardan
Recent news which mentions Chardan
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
September 18, 2020
Tickers
MRNA
From Benzinga
Moderna Analysts Say COVID-19 Vaccine Contract Reflects Pricing Risk, Shows Ability To Scale
August 12, 2020
From Benzinga
From Benzinga
From Benzinga
Adverum Biotech Shares Move Higher On Positive Wet AMD Gene Therapy Data
February 10, 2020
Tickers
ADVM
From Benzinga
Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster
August 20, 2019
From Benzinga
6 Gene Therapy M&A Targets On The Radar
March 27, 2019
From Benzinga
Sell-Side Picks Top Gene Therapy Takeout Candidates Following Spark Therapeutics Deal
February 25, 2019
From Benzinga
Chardan Stays Bullish On Vuzix After Q2 Print
August 10, 2018
From Benzinga
Sarepta's Clinical Hold Could Be A Solid Biosciences Catalyst, Says Bullish Chardan Analyst
July 26, 2018
From Benzinga
From Benzinga
3 Possible Outcomes From The Clinical Hold On Crispr Therapeutics's Sickle Cell Candidate
May 31, 2018
From Benzinga
Chardan's Top Pick For 2018: Gene Therapy Firm Uniqure
April 24, 2018
From Benzinga
Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson
April 13, 2018
From Benzinga
Analyst: AveXis M&A Could Support Interest In Regenxbio
April 09, 2018
From Benzinga
Analyst: AveXis M&A Could Support Interest In Regenxbio
April 09, 2018
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Novavax Shares Rise 30% On Positive Data, But Risks Remain
March 01, 2018
From Benzinga
Chardan: Solar Decision Removes Uncertainty For Sunworks Investors
January 23, 2018
Tickers
SUNW
From Benzinga
For Smart Glasses Maker Vuzix, 2018 Could Be 'Transformative'
December 26, 2017
From Benzinga
There Could Be 109% Upside In uniQure As Company Advances Gene Therapy Into Clinical Trials
October 20, 2017
From Benzinga
Sage Therapeutics Falls Hard After Brexanolone Drug Fails Phase III Testing
September 12, 2017
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.